IMPORTANCE: The burden of neurological disorders is increasing, but access to care is limited. Providing specialty care to patients via telemedicine could help alleviate this growing problem. OBJECTIVE: To evaluate the feasibility, effectiveness, and economic benefits of using web-based videoconferencing (telemedicine) to provide specialty care to patients with Parkinson disease in their homes. DESIGN: A 7-month, 2-center, randomized controlled clinical trial. SETTING:Patients' homes and outpatient clinics at 2 academic medical centers. PARTICIPANTS: Twenty patients with Parkinson disease with Internet access at home. INTERVENTION: Care from a specialist delivered remotely at home or in person in the clinic. MAIN OUTCOME MEASURES: The primary outcome variable was feasibility, as measured by the percentage of telemedicine visits completed as scheduled. Secondary outcome measures included clinical benefit, as measured by the 39-item Parkinson Disease Questionnaire, and economic value, as measured by time and travel. RESULTS:Twenty participants enrolled in the study and were randomly assigned to telemedicine (n = 9) or in-person care (n = 11). Of the 27 scheduled telemedicine visits, 25 (93%) were completed, and of the 33 scheduled in-person visits, 30 (91%) were completed (P = .99). In this small study, the change in quality of life did not differ for those randomly assigned to telemedicine compared with those randomly assigned to in-person care (4.0-point improvement vs 6.4-point improvement; P = .61). Compared with in-person visits, each telemedicine visit saved participants, on average, 100 miles of travel and 3 hours of time. CONCLUSION AND RELEVANCE: Using web-based videoconferencing to provide specialty care at home is feasible, provides value to patients, and may offer similar clinical benefit to that of in-person care. Larger studies are needed to determine whether the clinical benefits are indeed comparable to those of in-person care and whether the results observed are generalizable. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01476306.
RCT Entities:
IMPORTANCE: The burden of neurological disorders is increasing, but access to care is limited. Providing specialty care to patients via telemedicine could help alleviate this growing problem. OBJECTIVE: To evaluate the feasibility, effectiveness, and economic benefits of using web-based videoconferencing (telemedicine) to provide specialty care to patients with Parkinson disease in their homes. DESIGN: A 7-month, 2-center, randomized controlled clinical trial. SETTING:Patients' homes and outpatient clinics at 2 academic medical centers. PARTICIPANTS: Twenty patients with Parkinson disease with Internet access at home. INTERVENTION: Care from a specialist delivered remotely at home or in person in the clinic. MAIN OUTCOME MEASURES: The primary outcome variable was feasibility, as measured by the percentage of telemedicine visits completed as scheduled. Secondary outcome measures included clinical benefit, as measured by the 39-item Parkinson Disease Questionnaire, and economic value, as measured by time and travel. RESULTS: Twenty participants enrolled in the study and were randomly assigned to telemedicine (n = 9) or in-person care (n = 11). Of the 27 scheduled telemedicine visits, 25 (93%) were completed, and of the 33 scheduled in-person visits, 30 (91%) were completed (P = .99). In this small study, the change in quality of life did not differ for those randomly assigned to telemedicine compared with those randomly assigned to in-person care (4.0-point improvement vs 6.4-point improvement; P = .61). Compared with in-person visits, each telemedicine visit saved participants, on average, 100 miles of travel and 3 hours of time. CONCLUSION AND RELEVANCE: Using web-based videoconferencing to provide specialty care at home is feasible, provides value to patients, and may offer similar clinical benefit to that of in-person care. Larger studies are needed to determine whether the clinical benefits are indeed comparable to those of in-person care and whether the results observed are generalizable. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01476306.
Authors: Russell E Glasgow; Edward H Wagner; Judith Schaefer; Lisa D Mahoney; Robert J Reid; Sarah M Greene Journal: Med Care Date: 2005-05 Impact factor: 2.983
Authors: Eric M Cheng; Kari Swarztrauber; Andrew D Siderowf; Mahmood S Eisa; Martin Lee; Stefanie Vassar; Erin Jacob; Barbara G Vickrey Journal: Mov Disord Date: 2007-03-15 Impact factor: 10.338
Authors: Kenneth A Follett; Frances M Weaver; Matthew Stern; Kwan Hur; Crystal L Harris; Ping Luo; William J Marks; Johannes Rothlind; Oren Sagher; Claudia Moy; Rajesh Pahwa; Kim Burchiel; Penelope Hogarth; Eugene C Lai; John E Duda; Kathryn Holloway; Ali Samii; Stacy Horn; Jeff M Bronstein; Gatana Stoner; Philip A Starr; Richard Simpson; Gordon Baltuch; Antonio De Salles; Grant D Huang; Domenic J Reda Journal: N Engl J Med Date: 2010-06-03 Impact factor: 91.245
Authors: E R Dorsey; R Constantinescu; J P Thompson; K M Biglan; R G Holloway; K Kieburtz; F J Marshall; B M Ravina; G Schifitto; A Siderowf; C M Tanner Journal: Neurology Date: 2006-11-02 Impact factor: 9.910
Authors: E R Dorsey; L M Deuel; C A Beck; I F Gardiner; N J Scoglio; J C Scott; F J Marshall; K M Biglan Journal: Neurology Date: 2011-04-27 Impact factor: 9.910
Authors: Amir Abdolahi; Nicholas Scoglio; Annie Killoran; E Ray Dorsey; Kevin M Biglan Journal: Parkinsonism Relat Disord Date: 2012-10-25 Impact factor: 4.891
Authors: E Ray Dorsey; Alistair M Glidden; Melissa R Holloway; Gretchen L Birbeck; Lee H Schwamm Journal: Nat Rev Neurol Date: 2018-04-06 Impact factor: 42.937
Authors: H Ben-Pazi; P Browne; P Chan; E Cubo; M Guttman; A Hassan; J Hatcher-Martin; Z Mari; E Moukheiber; N U Okubadejo; A Shalash Journal: Curr Neurol Neurosci Rep Date: 2018-04-13 Impact factor: 5.081
Authors: Ryan E Korn; Aparna Wagle Shukla; Maya Katz; H Tait Keenan; Steven Goldenthal; Peggy Auinger; William Zhu; Michael Dodge; Kyle Rizer; Meredith A Achey; Erica Byrd; Richard Barbano; Irene Richard; Kelly L Andrzejewski; Heidi B Schwarz; E Ray Dorsey; Kevin M Biglan; Gail Kang; Sulada Kanchana; Ramon Rodriguez; Caroline M Tanner; Nicholas B Galifianakis Journal: Neurol Clin Pract Date: 2017-08
Authors: Jayne R Wilkinson; Meredith Spindler; Stephanie M Wood; Steven C Marcus; Daniel Weintraub; James F Morley; Margaret G Stineman; John E Duda Journal: Neurol Clin Pract Date: 2016-06
Authors: E Ray Dorsey; Floris P Vlaanderen; Lucien Jlpg Engelen; Karl Kieburtz; William Zhu; Kevin M Biglan; Marjan J Faber; Bastiaan R Bloem Journal: Mov Disord Date: 2016-08-08 Impact factor: 10.338
Authors: E Ray Dorsey; Joseph D Wagner; Michael T Bull; Ashley Rizzieri; Justin Grischkan; Meredith A Achey; Todd Sherer; Sohini Chowdhury; Claire Meunier; Lily Cappelletti; Charlotte Rocker; Irene H Richard; Heidi Schwarz; Gail Kang; Stacy H Ahmad; Rachel A Biemiller; Kevin M Biglan Journal: J Parkinsons Dis Date: 2015 Impact factor: 5.568
Authors: Caroline M Tanner; Cheryl C Meng; Bernard Ravina; Anthony Lang; Roger Kurlan; Kenneth Marek; David Oakes; John Seibyl; Emily Flagg; Lisa Gauger; Dolores D Guest; Christopher G Goetz; Karl Kieburtz; Diane DiEuliis; Stanley Fahn; Robin A Elliott; Ira Shoulson Journal: Mov Disord Date: 2014-02-11 Impact factor: 10.338
Authors: E Ray Dorsey; Meredith A Achey; Christopher A Beck; Denise B Beran; Kevin M Biglan; Cynthia M Boyd; Peter N Schmidt; Richard Simone; Allison W Willis; Nicholas B Galifianakis; Maya Katz; Caroline M Tanner; Kristen Dodenhoff; Nathan Ziman; Jason Aldred; Julie Carter; Joohi Jimenez-Shahed; Christine Hunter; Meredith Spindler; Zoltan Mari; John C Morgan; Dedi McLane; Patrick Hickey; Lisa Gauger; Irene Hegeman Richard; Michael T Bull; Nicte I Mejia; Grace Bwala; Martha Nance; Ludy Shih; Lauren Anderson; Carlos Singer; Cindy Zadikoff; Natalia Okon; Andrew Feigin; Jean Ayan; Christina Vaughan; Rajesh Pahwa; Jessica Cooper; Sydney Webb; Rohit Dhall; Anhar Hassan; Delana Weis; Steven DeMello; Sara S Riggare; Paul Wicks; Joseph Smith; H Tait Keenan; Ryan Korn; Heidi Schwarz; Saloni Sharma; E Anna Stevenson; William Zhu Journal: Telemed J E Health Date: 2016-02-17 Impact factor: 3.536